The Zhitong Finance App learned that Zhiyun Health (09955) rose by more than 7% and rose 7.19% at press time to HK$3.13, with a turnover of HK$21.77 million.
According to the news, on March 21, financial reports showed that in 2023, Zhiyun Health's revenue continued to grow rapidly, with revenue reaching 3.69 billion yuan, an increase of 23.5% over the previous year. Non-IFRS (non-IFRS) adjusted net loss narrowed to 75.1 million yuan, a year-on-year decrease of 77.4%. The fourth quarter became the company's first profitable quarter, turning losses into profits in a single quarter.
Financial reports show that the three major business segments of Zhiyun Health are in-hospital solutions, the second is pharmacy solutions, and the third is personal chronic disease management solutions. Among them, in-hospital solution revenue was 2.87 billion yuan, accounting for more than 70%, the largest revenue source, up 31.5% year on year; pharmacy solution revenue was 660 million yuan, up 6.9% year on year; and personal chronic disease management solutions and other revenue was 160 million yuan.